Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer.

[1]  K. Do,et al.  Applications and Issues for Tissue Arrays in Target and Drug Discovery , 2005 .

[2]  K. Do,et al.  Clinical and Biomarker Correlates of Androgen-Independent, Locally Aggressive Prostate Cancer with Limited Metastatic Potential , 2004, Clinical Cancer Research.

[3]  P. Humphrey,et al.  Gleason grading and prognostic factors in carcinoma of the prostate , 2004, Modern Pathology.

[4]  L. Lessard,et al.  Expression of NF‐κB in prostate cancer lymph node metastases , 2004 .

[5]  R. Cohen,et al.  Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour , 2003, Pathology.

[6]  Eric Peltier,et al.  Evaluation of the interobserver reproducibility of Gleason grading of prostatic adenocarcinoma using tissue microarrays. , 2003, Human pathology.

[7]  T. McDonnell,et al.  Molecular markers of outcome after radiotherapy in patients with prostate carcinoma , 2003, Cancer.

[8]  L. Lessard,et al.  NF‐κB nuclear localization and its prognostic significance in prostate cancer , 2003 .

[9]  T. McDonnell,et al.  Immunohistochemical analysis of Bin1/Amphiphysin II in human tissues: Diverse sites of nuclear expression and losses in prostate cancer , 2003, Journal of cellular biochemistry.

[10]  T. McDonnell,et al.  The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  O. Kallioniemi,et al.  Clinical and functional target validation using tissue and cell microarrays. , 2002, Current opinion in chemical biology.

[12]  Miguel Srougi,et al.  Abnormal Expression of MDM2 in Prostate Carcinoma , 2001, Modern Pathology.

[13]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[14]  John T. Wei,et al.  BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. , 1999, The Journal of urology.

[15]  H. Moch,et al.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.

[16]  V. Kosma,et al.  Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer , 1999, The Prostate.

[17]  A. Borkowski,et al.  bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. , 1998, Urology.

[18]  Y. Tsujimoto,et al.  Role of Bcl‐2 family proteins in apoptosis: apoptosomes or mitochondria? , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[19]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[20]  T. Takeuchi,et al.  Immunohistochemical study of Fas, Fas ligand and interleukin-1 beta converting enzyme expression in human prostatic cancer. , 1998, British journal of urology.

[21]  M L Agarwal,et al.  The p53 Network* , 1998, The Journal of Biological Chemistry.

[22]  T. McDonnell,et al.  Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. , 1997, The Journal of urology.

[23]  John Calvin Reed,et al.  Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. , 1996, The American journal of pathology.

[24]  M. Campbell,et al.  Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.

[25]  P. Scardino,et al.  A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.

[26]  M. Piris,et al.  Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. , 2004, The American journal of pathology.

[27]  L. Lessard,et al.  NF-kappa B nuclear localization and its prognostic significance in prostate cancer. , 2003, BJU international.